rheumatoid arthritis
Conditions
Interventions
Treatment with Golimumab for patients with rheumatoid arthritis
Sponsors
Rheumatology, Internal MedicineJuntendo University School of Medicine, Juntendo Koshigaya Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 20 years old or more than 20 years old. 2. Patients who are in the condition of medium disease activity even treated with MTX 6 mg per week or more than 6 mg per week or with other biologics. 3. Patients whose lab data are WBC more than 4000,lymphocyte more than 1000 and negative result of Beta D glucan. 4.Patients fully understand and agree with this study with a consent letter.
Exclusion criteria
Exclusion criteria: 1.Patients who have history of allergy for golimumab. 2.Patients who have sepsis, severe infection,active tuberculosin infection, congestive heart disease, active B type viral hepatitis,nontuberculous mycobacterial infection, malignant disorders. 3.Patients who are not adequate for this study judged by investigator of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Nubmer of patients who are in the low disease activity at 52 weeks. 2.Number of golimumab-free patients who are in the low disease activity after at 52 weeks. | — |
Countries
Japan
Contacts
Public ContactShigeto Kobayashi
Juntendo University School of Medicine, Juntendo Koshigaya Hospital Rheumatology, Internal Medicine
Outcome results
None listed